Remove tag chemotherapy
article thumbnail

You can’t afford to get cancer

World of DTC Marketing

As cancer survival rates rise, so do the price tags of life-saving treatments. OPENING: American cancer patients spent more than $21 billion on their care in 2019. billion included out-of-pocket costs of $16.22 billion and patient time costs of $4.87

article thumbnail

Don’t Wait—Uncover the Clinical Endpoints that Will Matter to Payers and HCPs

PM360

This option grows more critical as new therapies become available with price tags as high as $3.5 Analysis of Time-to-Treatment Discontinuation of Targeted Therapy, Immunotherapy, and Chemotherapy in Clinical Trials of Patients with Non-Small-Cell Lung Cancer.” million for the new hemophilia gene therapy. Blumenthal, G.M.

article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

Bridging therapy has been shown to correlate with an inferior response to CAR T-cell therapy due to both progression of the chemotherapy-refractory malignant disease during the manufacturing period and increased toxicity. This is in addition to its considerable price tag.